Evaluating the causal relevance of diverse risk markers: horizontal systematic review

被引:36
作者
Kuper, Hannah [1 ]
Nicholson, Amanda
Kivimaki, Mika [2 ]
Aitsi-Selmi, Amina
Cavalleri, Gianpiero [3 ]
Deanfield, John E. [4 ]
Heuschmann, Peter [5 ]
Jouven, Xavier [6 ]
Malyutina, Sofia [7 ]
Mayosi, Bongani M. [8 ,9 ]
Sans, Susanna [10 ]
Thomsen, Troels [11 ]
Witteman, Jacqueline C. M. [12 ]
Hingorani, Aroon D. [2 ]
Lawlor, Debbie A. [13 ]
Hemingway, Harry [2 ]
机构
[1] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[2] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England
[3] Beaumont Hosp, Royal Coll Surg Ireland, Dublin 9, Ireland
[4] Great Ormond St Hosp Sick Children, Cardiothorac Unit, London, England
[5] Charite, Ctr Stroke Res Berlin, Berlin, Germany
[6] INSERM, Villejuif, France
[7] Russian Acad Med Sci, Inst Internal Med, Novosibirsk, Russia
[8] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa
[9] Univ Cape Town, ZA-7925 Cape Town, South Africa
[10] Inst Estudios Salud, Monitoring & Res Programme Chron Dis, Barcelona, Spain
[11] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark
[12] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[13] MRC CAiTE Ctr, Bristol, Avon, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2009年 / 339卷
基金
英国医学研究理事会; 英国惠康基金; 芬兰科学院;
关键词
CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; RANDOMIZED CONTROLLED-TRIALS; APOLIPOPROTEIN-E GENOTYPES; CARDIOVASCULAR-DISEASE; EUROPEAN GUIDELINES; CLINICAL-PRACTICE; MENDELIAN RANDOMIZATION; ARTERY-DISEASE; BLOOD-PRESSURE;
D O I
10.1136/bmj.b4265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To develop a new methodology to systematically compare evidence across diverse risk markers for coronary heart disease and to compare this evidence with guideline recommendations. Design "Horizontal" systematic review incorporating different sources of evidence. Data sources Electronic search of Medline and hand search of guidelines. Study selection Two reviewers independently determined eligibility of studies across three sources of evidence (observational studies, genetic association studies, and randomised controlled trials) related to four risk markers: depression, exercise, C reactive protein, and type 2 diabetes. Data extraction For each risk marker, the largest meta-analyses of observational studies and genetic association studies, and meta-analyses or individual randomised controlled trials were analysed. Results Meta-analyses of observational studies reported adjusted relative risks of coronary heart disease for depression of 1.9 (95% confidence interval 1.5 to 2.4), for top compared with bottom fourths of exercise 0.7 (0.5 to 1.0), for top compared with bottom thirds of C reactive protein 1.6 (1.5 to 1.7), and for diabetes in women 3.0 (2.4 to 3.7) and in men 2.0 (1.8 to 2.3). Prespecified study limitations were more common for depression and exercise. Meta-analyses of studies that allowed formal Mendelian randomisation were identified for C reactive protein (and did not support a causal effect), and were lacking for exercise, diabetes, and depression. Randomised controlled trials were not available for depression, exercise, or C reactive protein in relation to incidence of coronary heart disease, but trials in patients with diabetes showed some preventive effect of glucose control on risk of coronary heart disease. None of the four randomised controlled trials of treating depression in patients with coronary heart disease reduced the risk of further coronary events. Comparisons of this horizontal evidence review with two guidelines published in 2007 showed inconsistencies, with depression prioritised more in the guidelines than in our review. Conclusions This horizontal systematic review pinpoints deficiencies and strengths in the evidence for depression, exercise, C reactive protein, and diabetes as unconfounded and unbiased causes of coronary heart disease. This new method could be used to develop a field synopsis and prioritise future development of guidelines and research.
引用
收藏
页数:11
相关论文
共 38 条
[1]   The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases [J].
不详 .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (12) :839-869
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]   Association of apolipoprotein E genotypes with lipid levels and coronary risk [J].
Bennet, Anna M. ;
Di Angelantonio, Emanuele ;
Ye, Zheng ;
Wensley, Frances ;
Dahlin, Anette ;
Ahlbom, Anders ;
Keavney, Bernard ;
Collins, Rory ;
Wiman, Bjoern ;
de Faire, Ulf ;
Danesh, John .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (11) :1300-1311
[4]   Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels - A meta-analysis of 21 cohort studies including more than 300,000 persons [J].
Bogers, Rik P. ;
Bemelmans, Wanda J. E. ;
Hoogenveen, Rudolf T. ;
Boshuizen, Hendriek C. ;
Woodward, Mark ;
Knekt, Paul ;
van Dam, Rob M. ;
Hu, Frank B. ;
Visscher, Tommy L. S. ;
Menotti, Alessandro ;
Thorpe, Roland J., Jr. ;
Jamrozik, Konrad ;
Calling, Susanna ;
Strand, Bjorn Heine ;
Shipley, Martin J. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1720-1728
[5]   Dietary advice for reducing cardiovascular risk [J].
Brunner, E. J. ;
Thorogood, M. ;
Rees, K. ;
Hewitt, G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04)
[6]   C-reactive protein and coronary heart disease: a critical review [J].
Casas, J. P. ;
Shah, T. ;
Hingorani, A. D. ;
Danesh, J. ;
Pepys, M. B. .
JOURNAL OF INTERNAL MEDICINE, 2008, 264 (04) :295-314
[7]   Insight into the nature of the CRP-coronary event association using Mendelian randomization [J].
Casas, Juan P. ;
Shah, Tina ;
Cooper, Jackie ;
Hawe, Emma ;
McMahon, Alex D. ;
Gaffney, Dairena ;
Packard, Christopher J. ;
O'Reilly, Denis S. ;
Juhan-Vague, Irene ;
Yudkin, John S. ;
Tremoli, Elena ;
Margaglione, Maurizio ;
Di Minno, Giovanni ;
Hamsten, Anders ;
Kooistra, Teake ;
Stephens, Jeffrey W. ;
Hurel, Steven J. ;
Livingstone, Shona ;
Colhoun, Helen M. ;
Miller, George J. ;
Bautista, Leonelo E. ;
Meade, Tom ;
Sattar, Naveed ;
Humphries, Steve E. ;
Hingorani, Aroon D. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (04) :922-931
[8]   Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272
[9]   Medicine - Life cycle of translational research for medical interventions [J].
Contopoulos-Ioannidis, Despina G. ;
Alexiou, George A. ;
Gouvias, Theodore C. ;
Ioannidis, John P. A. .
SCIENCE, 2008, 321 (5894) :1298-1299
[10]   European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice [J].
De Backer, G ;
Ambrosioni, E ;
Borch-Johnsen, K ;
Brotons, C ;
Cifkova, R ;
Dallongeville, J ;
Ebrahim, S ;
Faergeman, O ;
Graham, I ;
Mancia, G ;
Cats, VM ;
Orth-Gomér, K ;
Perk, J ;
Pyörälä, K ;
Rodicio, JL ;
Sans, S ;
Sansoy, V ;
Sechtem, U ;
Silber, S ;
Thomsen, T ;
Wood, D .
EUROPEAN HEART JOURNAL, 2003, 24 (17) :1601-1610